Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

N/T PROTEIN CONTROL SY/L, M AND H

K-Number: K952593 · 1995-07-17

ApplicantBehring Diagnostics, Inc.
Decision Date1995-07-17
Product CodeDAD
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

N/T PROTEIN CONTROL SY/L, M AND H is the device name listed in this FDA 510(k) record. The listed applicant is Behring Diagnostics, Inc.. It received FDA 510(k) clearance on 1995-07-17 under 510(k) number K952593. The device is classified under product code DAD. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the N/T PROTEIN CONTROL SY/L, M AND H?

N/T PROTEIN CONTROL SY/L, M AND H is a medical device that received FDA 510(k) clearance on 1995-07-17. The listed applicant is Behring Diagnostics, Inc.. The 510(k) number is K952593.

When did N/T PROTEIN CONTROL SY/L, M AND H receive FDA 510(k) clearance?

N/T PROTEIN CONTROL SY/L, M AND H received FDA 510(k) clearance on 1995-07-17, under 510(k) number K952593.

Who is the listed applicant for N/T PROTEIN CONTROL SY/L, M AND H?

The FDA 510(k) record lists Behring Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for N/T PROTEIN CONTROL SY/L, M AND H?

The FDA product code for N/T PROTEIN CONTROL SY/L, M AND H is DAD.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Behring Diagnostics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K973832OPUS HLH CONTROLSK972929N ANTISERUM TO HUMAN ALBUMINK972840N ANTISERUM TO HUMAN TRANSFERRINK973202MODIFICATION OF OPUS FERRITIN TEST SYSTEMK972316OPUS D-DIMERK972116VON WILLEBRAND REAGENT

View all 145 devices →

Related Devices (Code: DAD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K993480K-ASSAY HAPTOGLOBINKamiya Biomedical Co.K972639TINA-QUANT HAPTOGLOBINBoehringer Mannheim Corp.K964301N-ASSAY TIA MULTI V-NLCrestat Diagnostics, Inc.K963286IMMAGE IMMUNOCHEMISTRY SYSTEM HAPTOGLOBIN (HPT) REAGENTBeckman Instruments, Inc.K915829IL TEST(TM) HAPTOGLOBIN (HPT)Instrumentation Laboratory COK911898RAICHEM(TM) SPIA(TM) HAPTOGLOBIN REAGENTReagents Applications, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑